Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
DiaMedica Therapeutics, Inc. (DMAC) had Free Cash Flow per Share of $-0.32 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-10.14M |
|
-- |
|
-- |
|
$10.50M |
|
$-10.50M |
|
$0.37M |
|
$-10.13M |
|
$-10.13M |
|
$-10.12M |
|
$-10.12M |
|
$-10.12M |
|
$-10.12M |
|
$-10.50M |
|
$-10.65M |
|
53.89M |
|
53.89M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$44.31M |
|
$0.13M |
|
$0.69M |
|
$45.00M |
|
$6.59M |
|
-- |
|
$0.07M |
|
$6.66M |
|
$38.34M |
|
$38.34M |
|
$38.34M |
|
53.93M |
|
| Cash Flow Statement Financials | |
$-17.20M |
|
$6.13M |
|
$0.55M |
|
$15.65M |
|
$5.13M |
|
$-10.52M |
|
$1.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.72 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.41% |
|
-26.41% |
|
-22.50% |
|
-26.41% |
|
$0.71 |
|
|
Free Cash Flow per Share |
$-0.32 |
$-0.32 |
|